Search a title or topic

Over 20 million podcasts, powered by 

Player FM logo

Automated Insulin Delivery Podcasts

show episodes
 
Artwork

1
Diabetes Technology Report

David Klonoff and David Kerr

icon
Unsubscribe
icon
icon
Unsubscribe
icon
Monthly
 
The world of diabetes research and innovation is moving forward at a lightning pace. At Diabetes Technology Society (DTS) we recognize the need for a free and easily accessible resource that provides clinicians, researchers, innovators and people with diabetes with up-to-date and authoritative information on the latest developments in diabetes technology research and innovation. Diabetes Technology Report is a new podcast from DTS co-hosted by endocrinologists David Klonoff (UCSF), and David ...
  continue reading
 
The Glucose Never Lies® Podcast is brought to you by John Pemberton, together with Chad, his innovation partner who helps turn ideas into production. Behind the scenes, the creative team brings research, stories, and lived experiences of type 1 diabetes into an accessible format — combining science, storytelling, and strategy to help people live better with diabetes. Support | Donate: The Glucose Never Lies® Podcast ☕ Coffee → https://www.buymeacoffee.com/jspfree2s 💙 Donate → https://www.pay ...
  continue reading
 
Diabetech covers diabetes technology, breaking news, research, and management tips through expert interviews and real-life experiences. Whether you’re living with diabetes, work in healthcare, or just love tech, this show keeps you in the loop on the latest in diabetes care.
  continue reading
 
Loading …
show series
 
We dive into type 3C diabetes, a lesser-known form that develops after pancreatic damage from pancreatitis, surgery, or trauma. Ivan Werning breaks down how it differs from type 1 and type 2, the challenges of delayed diagnosis, and the realities of managing both blood sugar and digestion. We also explore how he uses the CeQur Simplicity insulin pa…
  continue reading
 
Suggest guests or get in contact Episode 17 — GLP-1 in Type 1 Diabetes: Beyond Weight Loss, Towards Metabolic Therapy Go to the Podcast page for all the notes, insights, and further reading & listening. Subscribe to The Glucose Never Lies® and receive the Summary PDF with all the key take-home messages and practical implementation strategies. Suppo…
  continue reading
 
I sit down with Tandem Diabetes' Senior Director of Product Marketing, Ben Mar, to unpack all the big tech coming from the company and recent safety warnings users should be aware of. We get the first public video demo of the 7-day SteadiSet infusion set, unpack the upcoming tubeless Mobi option, and Ben shares updates on Libre 3 Plus integration a…
  continue reading
 
Suggest guests or get in contact Episode 16 — Diabetes & Driving: Why You Need to Be 5 to Drive Show summary PDF and full notes here Support The Glucose Never Lies® Podcast ☕ Buy Me a Coffee 💙 Donate Guest: Professor Pratik Choudhary (University of Leicester, Leicester Diabetes Centre; Chair, DVLA Medical Advisory Panel on Diabetes) Host: John Pemb…
  continue reading
 
Suggest guests or get in contact This bonus Episode 8B is a family special — co-created with my daughter Grace. It takes the science of activity lowering glucose and flips it into something fun: a rap we call 99 Problems (But Highs Ain’t One). The key message? When you’re above 10 mmol/L (180 mg/dL), just 20 minutes of activity can drop glucose by …
  continue reading
 
Diabetes tech often advances slowly because of hard constraints: safety, liability, FDA clearance, and reimbursement—so apps take years, pump designs stagnate, and algorithms lag behind what’s possible. In this episode, we unpack how those forces shape timelines and what’s being done to move faster without sacrificing safety. Joining me is Shannon …
  continue reading
 
DIY Loop user Taylor Patterson built an AI-powered food analysis tool right into the AID app—helping users take pictures, scan barcodes, or enter text and voice prompts to get carb estimates, nutrition breakdowns, and diabetes-oriented notes. In this episode, Taylor explains how he created the feature in just 30 minutes, how it’s already helping hi…
  continue reading
 
We cover ADCES 2025 updates on how diabetes educators are adapting to AI, new insights on mental health and eating disorders in type 1, and eye-opening stats about access to care. We also dive into the latest diabetes tech, including the Pivot pump, DIY systems, and carb awareness research. And lastly, we discuss major progress toward a cure for ty…
  continue reading
 
We dive into the growing off-label use of GLP-1 medications like Ozempic, Wegovy, and Mounjaro among people with type 1 diabetes. I'm joined by longtime diabetes advocate and healthcare executive Marie Schiller to explore the benefits, risks, and evolving research around these drugs. We discuss new studies, including the ADJUST-T1D trial, showing i…
  continue reading
 
AI-powered food tracking is changing how people with diabetes count carbs and manage their glucose. In this episode, I speak with Aurelian Briner, CEO and co-founder of the SNAQ app—an AI-driven diabetes app that uses photos, voice notes, and machine learning to estimate carbs, log meals, and predict glucose spikes. We dive into how AI is transform…
  continue reading
 
Suggest guests or get in contact Hosted by diabetes dietitian John Pemberton, this show blends science and real-life experience to make managing type 1 diabetes easier, clearer, and more human. Smart insights, practical tips, and honest conversations await. It's all about C-Peptide and what it means for people living with T1D! 🕒 [00:09] Think all T…
  continue reading
 
This episode explores the early days of diabetes data integration and the rise of open-source AID systems with Brandon Arbiter, Co-Founder and Acting CEO of Tidepool. Brandon shares how his passion for location data led to the creation of Tidepool, now a key platform in diabetes tech. We discuss the pivotal people who shaped the open source space, …
  continue reading
 
Suggest guests or get in contact In this deep-dive episode, John Pemberton explores the misunderstood world of insulin resistance in people with type 1 diabetes. Drawing on years of personal experience, clinical expertise, and the latest research, he breaks down why insulin resistance matters—even in a condition defined by insulin deficiency. Click…
  continue reading
 
Dexcom addresses growing concerns over G7 sensor failures, the recall of receivers with faulty alerts, and an FDA warning letter. We also discuss the upcoming 15-day Dexcom G7, AI food tracking and a new integration between Stelo and Oura Ring. Drop your questions and comments on YouTube. Join our Newsletter Learn about Omnipod 5 (today's sponsor)*…
  continue reading
 
In this episode, Justin speaks with Melissa Holloway, the founder of SmartStart and a type 1 for over 30 years, opens up about her personal fight to access an insulin pump after moving to the UK—and how that journey led her to become a force for change in the diabetes community. Together, they explore how one voice can make a difference and why com…
  continue reading
 
We break down the biggest diabetes tech and research highlights from the 2025 ADA Scientific Sessions. Justin is joined by CDCES Gary Scheiner to discuss new tubeless insulin pumps, an implantable continuous glucose monitor, and updates on a dual glucose-ketone sensor. We also explore cutting-edge research on islet cell therapies, ultra-concentrate…
  continue reading
 
In this live episode of Diabetech, I'm joined by Jen Greaves in Valencia, Spain! Jen is a fellow T1D, world traveler, and content creator who spent four months exploring Latin America—all while managing life with type 1. We talk about what it takes to travel long-term with T1D, from navigating insulin supply challenges to staying on top of tech and…
  continue reading
 
Over the last 8 months, I’ve been traveling the world as a digital nomad, and I want everyone with diabetes to know—it is possible to travel safely and confidently. Today I'm joined by my diabetes educator, Mary Rose, who helped guide me through my very first trip with type 1 diabetes! Mary Rose and I cover everything from what to pack and how to p…
  continue reading
 
We dive into growing concerns around reliability issues with the Dexcom G7. After posting a video online that sparked nearly 1,000 comments from users reporting sensor failures, it became clear that this wasn’t an isolated problem. To explore what’s going on, I’m joined by two experts in the diabetes space: Kamil of the Nerdabetic YouTube channel, …
  continue reading
 
Today we explore the evolution of continuous glucose monitors (CGMs) — from the first professional CGM in 1999 to the advanced tech driving today’s AID systems, and how these devices changed patient lives along the way. Dr. Grazia Aleppo, a leading endocrinologist and early CGM believer, joins to discuss early CGM innovations, the challenges of ado…
  continue reading
 
I sit down with someone who wore the first consumer insulin pump—the AutoSyringe We dive into what diabetes treatment was like at the time, how the early pump worked, and how decades of evolving tech have shaped her journey and inspired her to educate others. It’s a powerful look at how far we’ve come in diabetes innovation. Learn about Omnipod 5 (…
  continue reading
 
I sit down with veteran game developer and T1D dad Sam Glassenberg, creator of Level One—a new smartphone game designed to teach newly diagnosed patients and their families the fundamentals of T1D management. From insulin-to-carb ratios to the impact of exercise and fat on blood sugar, Level One turns complex concepts into fun, interactive levels. …
  continue reading
 
Today’s CGMs measure glucose through fluid under the skin—but what if we could measure it directly from the blood? Today we explore Glucotrack, an implantable device that could become the world’s first continuous blood glucose monitor (CBGM). I’m joined by Glucotrack's CEO and Chief Scientific Officer to discuss the major advantages this device cou…
  continue reading
 
I share my experience after nearly three months using the Tandem Mobi, the smallest tubed hybrid closed-loop pump currently available in the U.S. I’m joined by diabetes educator and fellow Mobi user David Mina to dive deep into how Tandem’s Control-IQ algorithm works — including updates with Control-IQ+ — and what to consider before switching from …
  continue reading
 
Suggest guests or get in contact In this episode of the Glucose Never Lies podcast, hosts John Pemberton and Louise discuss the intricacies of diabetes management, focusing on continuous glucose monitoring (CGM) systems. They explore various CGM features, including calibration, alarms, and connectivity with automated insulin delivery (AID) systems.…
  continue reading
 
We take a journey back to the roots of the #WeAreNotWaiting movement—before CGM follower apps—when a group of determined parents and developers built their own tools to monitor glucose remotely. I sit down with James Wedding, founder of the Nightscout Foundation, to talk about the early days of Nightscout, how it transformed life for families manag…
  continue reading
 
In this episode, we dive into the major shift happening in the U.S. diabetes tech industry: insulin pumps are moving from Durable Medical Equipment (DME) to pharmacy benefits, offering easier access, lower costs, and more flexibility for users. I’m joined by Jeff DelVerne, author of The Healthcare Economy Substack and Director of Payer Relations at…
  continue reading
 
In this episode, I sit down with Amy Tenderich, one of the first diabetes bloggers, whose open letter to Steve Jobs called for better, more user-friendly diabetes technology. That bold move launched her deeper into the world of diabetes advocacy and innovation, eventually leading her to create D-Data Exchange—a powerful forum where industry leaders…
  continue reading
 
Can we stop type 1 diabetes before it starts? I’m joined by Sam Reich, CEO of SAB Bio, and Dr. Mike Haller, a leading T1D researcher, to explore an innovative new therapy called SAB-142. Unlike traditional thymoglobulin, which is derived from rabbits, SAB’s therapy uses a fully human version produced by genetically engineered cows—potentially elimi…
  continue reading
 
Suggest guests or get in contact In this episode of the Glucose Never Lies podcast, hosts John Pemberton and Louise discuss the intricacies of diabetes management, focusing on continuous glucose monitoring (CGM) systems. They explore the importance of CGM accuracy, the standards set by regulatory bodies, and the significance of testing conditions i…
  continue reading
 
Suggest guests or get in contact In this episode of the Glucose Never Lies podcast, hosts John Pemberton and Louise delve into the intricacies of diabetes management, focusing on continuous glucose monitoring (CGM) systems. They discuss the importance of understanding CGM accuracy, the significance of study design in evaluating sensor performance, …
  continue reading
 
We explore Android APS (AAPS)—a powerful open-source automated insulin delivery system that runs on Android phones and uses the advanced o-ref algorithm. AAPS offers features like Dynamic ISF (Insulin Sensitivity Factor), Dynamic CR (Carb Ratio), Unannounced Meal detection (UAM), and Super Micro Boluses (SMBs), making it one of the most customizabl…
  continue reading
 
The twiist insulin pump from Sequel Med Tech is releasing in Q2 of 2025. is bringing a new spin to tubed pump therapy. I met with Sequel's CEO to dive into twiist's launch CGM integration with Libre 3 Plus to its advanced occlusion technology designed for more reliable insulin delivery. We also break down how patients will access twiist through pha…
  continue reading
 
Suggest guests or get in contact In this episode of the Glucose Never Lies podcast, John Pemberton shares insights from the ATTD 2025 conference, discussing advancements in diabetes management technologies, including automated insulin delivery systems and continuous glucose monitoring. He emphasizes the importance of early intervention with AID sys…
  continue reading
 
Endocrinologist David Ahn and I break down the biggest diabetes tech announcements from the ATTD conference in Amsterdam! We dive into the highly anticipated Twiist pump, the newly unveiled and more powerful Kaleido 2, Tandem’s game-changing Control IQ+ algorithm update, Dexcom’s 15-day sensor, and more. This was a HUGE week for diabetes innovation…
  continue reading
 
The ADA’s Standards of Care shape diabetes treatment, technology access, and insurance coverage worldwide. In this episode, we break down the latest updates, including a major new recommendation that all people with type 2 diabetes—regardless of insulin use—have access to CGM. We also explore the ADA’s stance on emerging diabetes technologies and w…
  continue reading
 
DIY Loop is one of the most powerful and customizable automated insulin delivery systems for type 1 diabetes, offering features like overrides, retroactive carb adjustments, and glycemic index logging. In this episode, fellow Loop user Jake Giles joins me to share our experiences getting started, the support (or lack thereof) from doctors, and a de…
  continue reading
 
Suggest guests or get in contact Welcome to The Glucose Never Lies Podcast! In this episode, we’re laying down the fundamentals of diabetes management—the essential principles you need to understand to make informed decisions about your health. We’ll break down: What happens when you eat carbohydrates and how your body processes glucose Why insulin…
  continue reading
 
Suggest guests or get in contact Welcome to The Glucose Never Lies podcast In today’s episode, we explore a game-changing approach to glucose control—activity snacking. If you’ve ever struggled with post-meal spikes, found insulin too slow to bring down highs, or wondered how movement could help stabilise your blood glucose, this episode is for you…
  continue reading
 
Suggest guests or get in contact Welcome to The Glucose Neverlies Podcast! When it comes to Automated Insulin Delivery (AID) systems, there is no single "best" option, only the right one for each individual. Choosing an AID system can feel overwhelming, but with the help of my good friend, colleague, and Diabetes Nurse Extraordinaire, Louise Collin…
  continue reading
 
Suggest guests or get in contact Welcome to The Glucose Neverlies Podcast In today’s episode, we are exploring the Tandem t:slim X2 with Control-IQ, a system that offers great power but also requires great responsibility. If you are considering this system or already using it, this episode will guide you through everything you need to know to make …
  continue reading
 
Suggest guests or get in contact Welcome to The Glucose Neverlies Podcast. In this episode, we’re taking a deep dive into the Medtronic 780G, a powerful Automated Insulin Delivery (AID) system designed to crush after-meal highs and optimise time in range. Just like the Hulk, the 780G is strong, aggressive, and highly automated, making it one of the…
  continue reading
 
Suggest guests or get in contact Welcome to The Glucose Neverlies Podcast. In this episode, we are exploring CamAPS FX, an Automated Insulin Delivery (AID) system that, much like Batman, relies on strategy, adaptability, and precise control to outsmart unpredictable glucose levels. If you’re looking for a system that allows multiple glucose targets…
  continue reading
 
Suggest guests or get in contact Welcome to The Glucose Neverlies Podcast. In this episode, we’re focusing on Omnipod 5, the sleek, high-tech Automated Insulin Delivery (AID) system that offers simplicity, automation, and a tubeless design. Much like Iron Man’s suit, Omnipod 5 is built for efficiency and ease, allowing for seamless insulin adjustme…
  continue reading
 
Suggest guests or get in contact Welcome to The Glucose Neverlies Podcast. In this episode, we’re diving into practical strategies to optimise time in range (TIR) when using Automated Insulin Delivery (AID) systems for type 1 diabetes. Managing blood glucose levels can be unpredictable, but AID systems have transformed diabetes care by automating i…
  continue reading
 
Sernova’s innovative Cell Pouch implants insulin-producing cells, and early trials have helped some people achieve full insulin independence for years. But challenges like immunosuppressants and scalability remain. In this episode, I’m joined by Jonathan Rigby, CEO of Sernova and a fellow T1D, to discuss how this technology works, the life-changing…
  continue reading
 
Loading …
Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play